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Loss of Adrenergic Augmentation of
Diastolic Intra-LV Pressure Difference in
Patients With Diastolic Dysfunction
Evaluation by Color M-Mode Echocardiography
Takahiro Ohara, MD, PHD,* Cassie L. Niebel, BS,† Kelley C. Stewart, PHD,†
John J. Charonko, PHD,† Min Pu, MD, PHD,* Pavlos P. Vlachos, PHD,†
William C. Little, MD*
Winston-Salem, North Carolina; and Blacksburg, Virginia
O B J E C T I V E S The aim of this study was to evaluate the hypothesis that the adrenergic response
of the intraventricular pressure difference (IVPD) is reduced in patients with preserved ejection fraction
(EF) and diastolic dysfunction (DD).
B A C KG ROUND In early diastole, there is a progressive IVPD extending from the left atrium (LA) to
the left ventricular (LV) apex. In response to adrenergic stimulation, as occurs during exercise, the IVPD
increases allowing rapid ﬁlling without an abnormal increase in LA pressure. Patients with heart failure
with a reduced EF have impaired adrenergic augmentation of the IVPD.
METHOD S We studied 166 consecutive patients undergoing dobutamine stress echocardiography who
had no inducible ischemia and an EF 50%, of which 21 had normal diastolic function, 14 had impaired
relaxation (grade 1), 80 had pseudonormal ﬁlling (grade 2), and 51 had restrictive ﬁlling (grade 3). Color
M-mode Doppler (CMMD) images of mitral inﬂow were obtained at rest and during low (10 g/kg/min) and
peak (20 to 40 g/kg/min) doses of dobutamine. The total IVPD from the LA to LV apex, LA to mid-LV, and
mid-LV to the LV apex were calculated using the CMMD data to integrate the Euler equation.
R E S U L T S Total IVPD was not different between groups at rest. With dobutamine, the total IVPD
increased by 2.20  1.95 mm Hg in normal subjects and by only 0.73 1.33 mm Hg, 1.84 1.63 mm Hg, and
1.08  1.57 mm Hg in patients with grades 1, 2, and 3 DD, respectively. This difference was due to a
failure in augmentation of IVPD from the mid-LV to the LV apex, indicating reduced apical ventricular
suction with DD, whereas the IVPD from the LA to the mid-LV responded similarly to dobutamine in
normal subjects and those with DD.
CONC L U S I O N S In patients with preserved EF, DD is associated with a reduced adrenergic
augmentation of the IVPD from the mid-LV to the LV apex, reﬂecting less apical suction. (J Am Coll
Cardiol Img 2012;5:861–70) © 2012 by the American College of Cardiology Foundation
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862n early diastole, rapid left ventricular (LV) relax-
ation and recoil of elastic elements that were
compressed during ejection produced a progressive
intraventricular pressure difference (IVPD) ex-
tending from the left atrium (LA) to the apex of the
LV (1). This IVPD rapidly accelerates blood into
the LV in early diastole (1). In response to adren-
ergic stimulation, as occurs during exercise, the
early diastolic IVPD normally increases due to a
See page 871
decrease in minimum LV pressure, allowing for
more rapid filling without an abnormal increase in
LA pressure (2–4). This larger IVPD results from
both ejection to lower end-systolic volume and more
rapid LV relaxation. Patients with heart failure (HF)
and reduced ejection fraction (EF) have a
reduced response to adrenergic stimulation
due to down-regulation and uncoupling of
beta receptors (5–7). As a result, in HF with
reduced EF, the decrease of early diastolic
LV pressure in response to adrenergic stim-
ulation is reduced (2,8,9). Thus, the
exercise-induced increased early diastolic
filling rate in patients with reduced EF is
dependent upon an increase in LA pressure
(9). The reduction of IVPD in patients with
reduced EF is due to both reduced inertial
acceleration and increased convective decel-
eration from a dilated ventricle (2).
An abnormal increase in LA pressure
during exercise is also present in patients
with HF and a preserved EF (10). How-
ever, the IVPD response in patients with
diastolic dysfunction and preserved EF is
nknown. We hypothesize that the response of
VPD to adrenergic stimulation is reduced in pa-
ients with diastolic dysfunction and preserved EF.
ccordingly, we noninvasively evaluated the IVPD
nd its spatial distribution in patients with pre-
erved EF and diastolic filling abnormalities during
obutamine stress echocardiography.
M E T H O D S
Patients. This study was approved by the institu-
ional review boards of Wake Forest School of
edicine and Virginia Tech. Patients at Wake
orest Baptist Medical Center referred for clinically
ndicated pharmacological stress echocardiography
ere eligible for this study. Patients with an EF
ular
pler
sure
ar50%, inducible ischemia, or poor echo images Tere excluded. We also excluded the patients with
ignificant mitral regurgitation or stenosis, a pros-
hetic mitral valve, constrictive pericarditis, and
yssynchrony in which E/e= is not reliable.
Echocardiography. Echocardiography was per-
formed using an iE33 ultrasound system with a
multiple frequency transducer (Philips Medical Sys-
tems, Andover, Massachusetts). Before stress echo-
cardiography, patients had a complete transthoracic
echocardiogram. LV end-diastolic volume, end-
systolic volume, stroke volume, and EF were calcu-
lated by the modified Simpson method using an
apical 4-chamber view. Doppler echocardiographic
variables were recorded as previously reported (11).
Dobutamine stress echocardiography was per-
formed according to a standard protocol (12). Beta-
blockers were stopped the morning of the exami-
nation. After obtaining baseline observations,
dobutamine was infused at 10 g/kg/min and
ncreased by 10 g/kg/min every 3 min up to 40
g/kg/min to obtain 80% of the age-predicted
maximum heart rate or clinically relevant symptoms
(chest pain or dyspnea), electrocardiogram change,
hypotension, or hypertension (systolic blood pres-
sure 240 mm Hg). If the target heart rate was not
obtained at the maximum infusion rate (40 g/kg/min),
atropine sulfate was infused. In addition to standard
images to evaluate LV wall motion, color M-mode
Doppler (CMMD) images, transmitral inflow
Doppler, and tissue Doppler of mitral annular
motion were obtained at rest, and during low- and
peak-dose dobutamine infusion. CMMD images
were recorded with a cursor parallel to mitral inflow
in an apical 4-chamber view.
Diastolic function was assessed as: grades 1
(impaired relaxation), 2 (pseudonormal filling), and
3 (restrictive filling) according to the European
Association of Echocardiography/American Society
of Echocardiography recommendations (11).
Hemodynamics. The heart rate and systolic and
diastolic blood pressure were recorded at rest, and
during the low- and peak-dose infusion of dobut-
amine. Using these data and stroke volume, hemo-
dynamic parameters, such as systemic vascular re-
sistance, systemic arterial compliance, and effective
aortic elastance, were calculated (see Online Ap-
pendix A for additional information).
IVPD measurement. The CMMD images were an-
lyzed in MATLAB (The MathWorks, Natick,
assachusetts) using an image-processing algo-
ithm (13). The images were reconstructed using a
e-aliasing technique similar to that used byA B B R E V I A T I O N S
A N D A C R O N YM S
a= late diastolic mitral ann
velocity
CMMD color M-mode Dop
e= early diastolic mitral
annular velocity
EF ejection fraction
HF heart failure
HFpEF heart failure with a
reserved ejection fraction
VPD intraventricular pres
difference
LA left atrium/atrial
LV left ventricle/ventricul
s= systolic mitral annularhomas et al. (14) and Rovner et al. (15).
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863The 1-dimensional, incompressible, Euler equa-
tion, shown in Equation 1, where P is the pressure,
 is constant blood density, and v is velocity, s is
osition, and t is time, was used to calculate the
elative pressures within the region of interest from
he reconstructed velocity field. The pressure dif-
erence at each point along a scan line was measured
elative to the position of the mitral annulus just
efore mitral valve opening by calculating the line
ntegral between them (2,16,17). The first term
f the right side of Equation 1 is the inertial
omponent, and the second term is the convective
omponent.
P
s
 . vt  v . vs  [1]
From the temporal profile of the LV apex pres-
sure relative to LA pressure, the peak IVPD from
the mitral valvular annulus to the LV apex was
calculated as previously described by Greenberg et
al. (17) and Rovner et al. (15) (Fig. 1). This method
Figure 1. IVPD Measurement
(A) Four-chamber view showing mitral inﬂow; (B) corresponding co
relative to LA pressure (LAP); (D) spatial proﬁle of IVPD at peak neg
sponding positions of mitral annulus, mid-LV, and LV apex; the red
Color M-mode Doppler (CMMD) images (B) were recorded with the
1-dimensional, incompressible, Euler equation, shown in Equation 1
pressure difference at each point along a scan line was measured r
opening by calculating the line integral between them. A temporal
and the peak negative IVPD in early diastole was identiﬁed (C). At t
valvular annulus to the LV apex and the IVPD from the LA to mid-L
were measured (D). IVPD  left ventricular intraventricular pressure
annulus.has been validated by comparison to direct mea-
surements with micromanometers (2,17). IVPD
from the LA to mid-LV and IVPD from mid-LV
(2 cm from the mitral annulus) to LV apex were
also calculated (Fig. 1). IVPD values were measured
from 3 beats, and the mean values were used for the
final analysis.
Statistics. Numerical data were shown as mean and
standard deviation unless otherwise mentioned.
Numerical data were compared between diastolic
functional grades by 1-way analysis of variance with
Dunnett’s post-hoc test using the normal group as
reference, unless otherwise mentioned. Categorical
data were compared with a chi-square method.
Responses to dobutamine infusion by diastolic
functional grades were compared using 2-way anal-
ysis of variance with repeated measure(s). Pearson
correlation was performed to determine the associ-
ation between the response of IVPD to the infusion
of dobutamine and that of systolic mitral annular
velocity (s=). A 2-tailed probability (p) value 0.05
was accepted as significant.
-mode Doppler image; (C) temporal proﬁle of LV apex pressure
e IVPD from LA to LV apex. The blue dotted line shows corre-
hed line shows the time of peak negative IVPD in early diastole.
sor parallel to mitral inﬂow in an apical 4-chamber view (A). The
s used to calculate the pressure gradients at each point. The
ve to the position of the mitral annulus just prior to mitral valve
ﬁle of LV apex pressure relative to LA pressure was generated,
iming of the peak negative IVPD, the peak IVPD from the mitral
d IVPD from mid-LV (2 cm from the mitral annulus) to LV apex
ference; LA  left atrium; LV  left ventricle; MA  mitrallor M
ativ
das
cur
, wa
elati
pro
he t
V an
dif
p
h
T
f
p
fi
f
s
s
(
t
b
d
t
d
d
t
3
n
t
a
r
c
r
o
h
g
d
v
d
s
c
RF  restrictive ﬁlling; THR
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 9 , 2 0 1 2
S E P T E M B E R 2 0 1 2 : 8 6 1 – 7 0
Ohara et al.
Adrenergic Diastolic Augmentation
864R E S U L T S
Patient characteristics. We studied 166 consecutive
atients undergoing stress echocardiography who
ad no inducible ischemia and a preserved EF.
wenty-one of the subjects had normal diastolic
unction, 14 impaired relaxation (grade 1), 80
seudonormal filling (grade 2), and 51 restrictive
lling (grade 3). Patient characteristics by diastolic
unctional grade are shown in Table 1.
Hemodynamic response. At rest, patients with dia-
tolic dysfunction grades 2 and 3 had higher
ystolic blood pressures than the normal subjects
see Online Appendix B for additional informa-
ion). Other hemodynamic variables were similar
etween normal subjects and those with diastolic
ysfunction. LV dimensions were similar be-
ween patient groups at rest and during peak
acteristics
Normal
(n  21)
Grade 1 (I
(n  14)
50 11 64 13
14 (67) 10 (71)
ase 6 (29) 1 (7)
1 (5) 0 (0)
14 (67) 9 (64)
4 (19) 1 (7)
11 (52) 6 (43)
6 (29) 3 (21)
9 (43) 5 (36)
8 (38) 6 (43)
5 (24) 3 (21)
11 (52) 5 (36)
ameter
mm 36 6 34 4
s, g 144 50 144 48
ine stress echocardiography
8 (38) 8 (57)
1 (5) 0 (0)
11 (52) 6 (43)
1 (5) 0 (0)
gical stress
se, g/kg/min 37 6 39 4
15 (71) 7 (50)
20 (95) 14 (100)
se event 1 (5) 0 (0)
n (%). *Analysis of variance or chi-square test as appropriate; †p  0.05 versus n
erting enzyme inhibitor; ARB  angiotensin receptor blocker; BB  beta-blocker; C
 target heart rate.obutamine infusion. eThe chronotropic responses to the infusion of
obutamine were similar between the groups except
hat at peak dobutamine infusion, patients with grade
diastolic dysfunction achieved lower heart rates than
ormal subjects (see Online Appendix B for addi-
ional information). However, the ratios of the
chieved heart rate to age-predicted maximum heart
ate were similar between groups. All groups increased
ardiac output to approximately 7 l/min from the
esting value of approximately 4 l/min. This increase
f cardiac output was predominantly due to increase in
eart rate. Although the EF increased in all the
roups, end-diastolic and end-systolic volumes both
ecreased, which resulted in a decrease in stroke
olume. In all groups, systemic vascular resistance
ecreased; however, aortic compliance decreased, con-
istent with an increase in the pulsatile component of
ardiac afterload. Total LV afterload, evaluated as
Grade 2 (PN)
(n  80)
Grade 3 (RF)
(n  51) p Value*
61 12† 64 13† 0.01
40 (50) 22 (43) 0.13
17 (21) 15 (29) 0.31
1 (1) 1 (2) 0.70
65 (81) 44 (86) 0.13
35 (44) 22 (43) 0.01
42 (53) 29 (57) 0.83
23 (29) 22 (43) 0.25
45 (56) 34 (67) 0.10
38 (48) 26 (51) 0.78
30 (38) 18 (35) 0.49
39 (49) 25 (49) 0.79
37 6 38 5 0.11
155 47 180 65† 0.02
0.84
39 (49) 28 (55)
2 (3) 2 (4)
36 (45) 21 (41)
3 (4) 0 (0)
37 6 36 7 0.52
49 (61) 31 (61) 0.64
73 (91) 44 (86) 0.36
7 (9) 7 (14)
al by Dunnett’s post-hoc test.
calcium channel blocker; IR  impaired relaxation; PN  pseudonormal ﬁlling;Table 1. Clinical Char
R)
Background
Age, yrs †
Male
End-stage renal dise
Heart failure
Hypertension
Diabetes mellitus
Dyslipidemia
Drugs
CCB
BB
ACEI/ARB
Diuretics
Statin
Echocardiographic par
Left atrial diameter,
Left ventricular mas
Indication of dobutam
Screening
Dyspnea
Chest pain
Other symptoms
Maximum pharmacolo
Peak dobutamine do
Atropine usage
Reason for termination
End of protocol/THR
Any symptom/adver
Values are mean  SD or orm
ACEI  angiotensin-conv CB ffective aortic elastance, increased in all groups. These
w
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865hemodynamic responses were similar between normal
subjects and those with diastolic dysfunction.
Doppler echocardiography. The e= and s= velocities
ere significantly correlated at rest (r  0.51, p 
.0001) (Table 2). During peak dobutamine infusion,
= was augmented in all the groups. However, the
agnitude of the augmentation of s= was less in
atients with diastolic function grades 2 and 3 than in
ormal subjects. We were unable to constantly mea-
ure e= during stress because of fusion of the early
iastolic mitral annular velocity (e=) and late diastolic
itral annular velocity (a=) waves.
Table 2. Doppler Echocardiographic Variables
Normal
n Mean  SD n
E at rest, cm/s 21 89 16 14
A at rest, cm/s 21 69 18 14
E/A at rest 21 1.37 0.44 14
Deceleration time at rest, ms 20 221 39 13
e’ at rest, cm/s 21 10.9 1.2 14
a’ at rest, cm/s 21 10.2 1.9 14
s’, cm/s
Rest 16 8.6 1.4 11
Peak dose 16 15.2 3.9 11
∆ (peak dose  at rest) 16 6.6 3.7 11
E/e’ at rest 21 8.2 1.6 14
*Analysis of variance (ANOVA); †p  0.05 versus normal by Dunnett’s post-hoc
a=  late diastolic mitral annular velocity; e=  early diastolic mitral annula
Table 3. IVPD at Rest and During Dobutamine Infusion
Normal
n Mean  SD n
Total IVPD
At rest 21 2.80 1.07 1
Low dose 21 3.91 2.21 1
Peak dose 21 5.00 1.74 1
∆ (peak dose  at rest) 21 2.20 1.95 1
IVPD from LA to mid-LV
At rest 21 1.58 0.59 1
Low dose 21 2.12 0.99 1
Peak dose 21 2.29 0.89 1
∆ (peak dose  at rest) 21 0.71 0.82 1
IVPD from mid-LV to LV apex
At rest 21 1.40 0.80 1
Low dose 21 2.05 1.47 1
Peak dose 21 3.12 1.24 1
∆ (peak dose  at rest) 21 1.73 1.29 1
*Analysis of variance with repeated measures; †p  0.05 versus normal by Dun
IVPD  intraventricular pressure difference; LA  left atrium; LV  left ventricleIVPD responses to dobutamine infusion by diastolic
functional grade. Patients with normal diastolic
unction had similar IVPD to patients with diastol-
c dysfunction at rest. All groups increased the IVPD
n response to dobutamine (Table 3). However, at
eak dobutamine, the patients with diastolic dysfunc-
ion had a smaller increase in the IVPD than patients
ith normal diastolic function (Table 3, Figs. 2 and 3).
oth normal subjects and patients with diastolic dys-
unction showed similar increases of IVPD from the
A to mid-LV in response to dobutamine (Fig. 3B).
he difference in the total IVPD in the diastolic
rade 1 (IR) Grade 2 (PN) Grade 3 (RF
Mean  SD n Mean  SD n Mean 
57 10† 80 76 15† 51 98
66 24 80 81 18† 51 97
0.94 0.29† 80 0.98 0.3† 51 1.08
255 74 79 241 50 51 245
8.7 1.3 80 7.2 1.3† 51 6.1
11.4 2.4 80 9.6 1.9† 51 8.5
9.0 3.1 75 7.3 1.2† 45 6.8
14.7 2.3 75 12.1 3.0† 45 10.4
5.7 2.2 75 4.8 2.8† 45 3.6
6.6 1.1 80 10.5 1.3† 51 16.3
; ‡ANOVA with 1 repeated measure.
ocity; s=  systolic mitral annular velocity; other abbreviations as in Table 1.
rade 1 (IR) Grade 2 (PN) Grade 3 (RF
Mean  SD n Mean  SD n Mean 
2.12 0.96 80 2.62 1.08 51 3.15
2.61 0.96† 80 3.92 1.6 51 4.07
2.85 1.03† 80 3.66 1.48† 51 4.23
0.73 1.33† 80 1.04 1.63† 51 1.08
1.09 0.39 80 1.49 0.57 51 1.86
1.24 0.38† 80 1.87 0.72 51 2.16
1.79 0.64 80 1.80 0.71† 51 2.37
0.70 0.84 80 0.31 0.77 51 0.51
1.27 0.64 80 1.35 0.76 51 1.52
1.55 0.79 80 2.27 1.26 51 2.08
1.41 0.59† 80 2.19 1.04† 51 2.14
0.15 0.72† 80 0.84 1.12† 51 0.63
’s post-hoc test.G )
SD p Value*
21 0.01
24† 0.01
0.44† 0.01
56 0.25
1.3† 0.01
2.2† 0.01
0.01‡
1.1†
2.3†
2.1†
3.3† 0.01
testG )
SD p Value*
0.02
4 1.20
4 1.48
4 1.59
4 1.57†
0.11
4 0.84
4 0.88
4 0.96
4 1.13
0.01
4 0.72
4 0.95
4 1.29†
4 1.32†
nett
; other abbreviations as in Table 1.
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866dysfunction group was due to less augmentation
of the IVPD from mid-LV to the apex in response to
the peak-dose infusion of dobutamine (Fig. 3C). The
results were similar in the patients who had not been
receiving beta-blockers (Online Appendix C). Results
were also similarly analyzed by tertiles of e= (Online
ppendix D). There was reduced dobutamine aug-
entation of the mid-LV to apex IVPD in the
Figure 2. Examples of IVPD During Dobutamine Stress Echocard
(A to G) Images from a subject with normal diastolic function, 5
with pseudonormal ﬁlling pattern, 69-year-old female, and an EF
sponding tissue Doppler image at septal mitral annulus; (B, C, D
proﬁle images of IVPD; (B, E, I, and L) images at rest; (C, F, J, an
and N) images during peak-dose dobutamine infusion. Red dash
the dotted line shows the change of peak IVPD in response to
tion had a smaller increase in the IVPD than patients with norm
bpm  beats/min; e=  early diastolic mitral annular velocity; EF
Figure 1.atients with e= 6.5 cm/s. cThis difference in the response of IVPD between
ormal and diastolic dysfunction was predomi-
antly due to reduced adrenergic augmentation of
he inertial acceleration with the peak-dose infusion
f dobutamine, whereas convective deceleration was
ot different between groups (Fig. 4).
The change of IVPD in response to the infusion
f dobutamine significantly correlated with the
raphy
ar-old male, and an EF of 54%; (H to N) images from a subject
63%. (A and B) Transmitral inﬂow Doppler image and corre-
J, and K) color Doppler images; (E, F, G, L, M, and N) temporal
) images during low-dose dobutamine infusion; and (D, G, K,
line shows the timing of peak negative IVPD in early diastole;
e infusion of dobutamine. The patients with diastolic dysfunc-
iastolic function in response to the infusion of dobutamine.
ejection fraction; HR  heart rate; other abbreviations as iniog
4-ye
of
, I,
d M
ed
th
al d
hange of s= to dobutamine (Fig. 5).
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In early diastole, the rapid relaxation of the LV
Peak DoseLow DoseRest
Normal, n = 21
Grade 1 (IR), n = 14
Grade 2 (PN), n = 80
Grade 3 (RF), n = 51
IV
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m
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g
p (interaction) = 0.017
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A
B
C
Figure 3. IVPD Responses to Dobutamine Infusion by Diastolic
Functional Grades
(A) IVPD; (B) IVPD from LA to mid-LV; (C) IVPD from mid-LV to LV
apex. *p  0.05 versus normal; †p  0.01 versus normal; ‡p  0.001
versus normal. IR  impaired relaxation; PN  pseudonormal ﬁlling;
RF  restrictive ﬁlling; other abbreviations as in Figures 1 and 2.generates a progressive pressure difference from theLA to the LV apex, resulting in rapid early diastolic
filling. This IVPD is considered a manifestation of
LV suction (18–20). The IVPD can now be non-
invasively calculated using the data obtained with
CMMD to integrate the Euler equation (2,16,17).
The pressure difference is generated by inertial
acceleration driven by the recoil of elastic elements
compressed during ejection and is reduced by con-
vective deceleration (2,21,22). The reduction of
IVPD in patients with reduced EF is due to both
reduced inertial acceleration and increased convec-
tive deceleration resulting from flow into a dilated
ventricle (2). Parker et al. (23) found that enhanced
LV relaxation with dobutamine measured using the
time constant was preserved in patients with HF
Peak DoseLow DoseRest
Normal, n = 21
Grade 1 (IR), n = 14
Grade 2 (PN), n = 80
Grade 3 (RF), n = 51
 
In
er
tia
l I
VP
D,
 
m
m
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g
0
2
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p (interaction) = 0.042
Peak DoseLow DoseRest
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e
c
tiv
e 
IV
PD
, 
m
m
 H
g
-0.8
-0.6
-0.4
-0.2
0.0
p (interaction) = 0.894
A
B
Figure 4. Responses to Dobutamine Infusion by Inertial
Acceleration and Convective Deceleration of IVPD
(A) Inertial IVPD; (B) convective IVPD. *p  0.05 versus normal;
†p  0.01 versus normal; ‡p  0.001 versus normal. Abbrevia-
tions as in Figures 1 and 3.and reduced EF. However, Yotti et al. (2) found a
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868blunted response to adrenergic stimulation of the
IVPD in the patients with HF and reduced EF.
Our study found that subjects with diastolic dys-
function and a preserved EF have a reduced adren-
ergic augmentation of the IVPD between the LA
and LV apex, predominantly due to reduced inertial
acceleration between the mid-LV and LV apex
(Fig. 3).
The IVPD can be increased due to a fall in LV
diastolic pressures or increase in LA pressure. Al-
terations in LA pressure impact the IVPD between
the LA and the inflow tract, whereas LV suction
produces a progressive IVPD, thus the pressure
difference between mid-LV to LV apex differen-
tiates LV filling resulting from LV suction and
filling predominately due to an increase in LA
pressure (13,18,19,24). Our observation of re-
duced dobutamine augmentation of the IVPD
from mid-LV to LV apex in patients with dia-
stolic dysfunction is consistent with diminished
adrenergic augmentation of LV suction and may
contribute to exercise intolerance in this patient
population (25).
Borlaug et al. (10) found exercise-induced
pulmonary hypertension and elevation of pulmo-
nary capillary wedge pressure in patients with
exertional dyspnea with preserved EF. Impaired
augmentation of the early IVPD in subjects with
diastolic dysfunction may help explain this obser-
vation (26).
Many factors other than diastolic function, in-
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Figure 5. Correlation Between s= and IVPD
IVPD  left ventricular intraventricular pressure difference; s=
systolic mitral annular velocity; other abbreviations as in Figures
1 and 3.cluding an impaired arterial vasodilation may con-tribute to exercise intolerance in HF with a preserved
EF (HFpEF) (26,27). However, we observed that
vascular responses to adrenergic stimulation were sim-
ilar between groups (Online Appendix B), consistent
with other observations (28).
Patients with grade 1 diastolic LV dysfunction
showed the lowest IVPD compared with grades 2
and 3 diastolic dysfunction. This was due to a
higher IVPD from the LA to mid-LV in the
patients with grades 2 and 3 diastolic dysfunction
than in patients with grade 1 diastolic dysfunc-
tion, suggesting that LA pressure was higher in
these patients. Interestingly, patients with grade
1 diastolic dysfunction had the smallest augmen-
tation. With grade 1 diastolic dysfunction, the
reduced adrenergic response was predominately
due to reduced inertial acceleration, whereas with
more severe diastolic dysfunction, it was predom-
inately due to greater convective deceleration.
During ejection, the mitral annulus is pulled
toward the LV apex. The velocity of this motion
(s=) is a measure of LV contractility. Normally, early
in diastole, the mitral annulus recoils, moving
rapidly away from the apex into the LA (29). This
is apparent on tissue Doppler as e= and may
contribute to the generation of the early diastolic
IVPD. Despite having normal EFs, we found that
both s= and e= were reduced at baseline in patients
with diastolic dysfunction. At rest, e= and s= were
significantly correlated (r  0.51, p  0.0001).
Although we could not reliably assess e= at peak
dobutamine due to fusion of e= and a=, there was a
reduction of the response of s= to dobutamine in
patients with diastolic dysfunction. Others have
observed that patients with HFpEF have impaired
augmentation of s= and e= in response to a low dose
of dobutamine (30) and is related to the 6-min walk
distance (31). These data suggest that a failure of
augmentation of longitudinal contraction and
lengthening in response to adrenergic stimulation
contributes to the reduced response of the IVPD in
patients with diastolic dysfunction.
Increased heart rate contributes to the normal
response to adrenergic stimulation through the
force-frequency and relaxation-frequency relation
(32,33), which may be preserved in patients with
HFpEF (34,35). When the patients in our study
did not achieve their target heart rate, atropine was
used, which potentially confounded the results.
However, the portion receiving atropine was similar
in the groups with and without diastolic dysfunc-
tion. Although some reported that there is chrono-
tropic incompetence in patients with HFpEF
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869(27,36), we did not observe the difference between
diastolic dysfunction subgroups in response to ad-
renergic stimulation.
The use of beta-blockers may potentially influ-
ence our results. The patients with advanced dia-
stolic dysfunction in our study were more likely to
be receiving beta-blockers (Table 1), although the
use did not reach statistical difference. In addition,
we stopped the beta-blocker on the day of exami-
nation, and we used high doses of dobutamine,
which overcomes the effect of beta-blockade. Fur-
thermore, limiting our analysis to the patients who
were not receiving beta-blockers produced similar
results.
We classified the patients’ diastolic dysfunction
using e= and E/e=. A more comprehensive evalua-Physiol 2004;286:H2425–33.
1
1
1
1
1
IEEE Computertime, LA volume, pulmonary venous flow, response
to the Valsalva maneuver, and other measures,
might have produced a more accurate classification
of our patients.
C O N C L U S I O N S
Patients with diastolic dysfunction and a normal EF
have reduced adrenergic augmentation of the IVPD
from the mid-LV to the apex. This is consistent
with reduced apical suction and may contribute to
exercise intolerance.
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